GlassScriptPhysician profile
John W Douglas
NPI 1972530335
$8,099.57
in general payments reported to CMS, 2019-2025
42 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what 83% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,517 · 2020: $800 · 2021: $1,757 · 2022: $585 · 2023: $230 · 2024: $1,575 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,439.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,991.49 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $1,200.53 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $400.92 | 2019-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $379.39 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols USA, LLC | $341.65 | 2019-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $341.32 | 2020-2025 | Acthar |
| Genzyme Corporation | $330.63 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $302.64 | 2020-2025 | Dupixent |
| Ani Pharmaceuticals, INC. | $286.55 | 2023-2025 | Purified Cortrophin Gel |
| Baxter Healthcare | $231.24 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Sunovion Pharmaceuticals INC. | $225.95 | 2019 | |
| Insmed, INC. | $176.64 | 2019-2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $175.00 | 2020-2025 | Glassia |
| Jazz Pharmaceuticals INC. | $168.28 | 2021-2022 | |
| Amgen INC. | $139.55 | 2021-2024 | Tezspire |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.